Integral Ad Science’s Gil Alexis II sells $263k in stock

Published 26/09/2025, 14:32
Integral Ad Science’s Gil Alexis II sells $263k in stock

Integral Ad Science Holding Corp (NASDAQ:IAS), a $1.69 billion digital advertising technology company, saw its Chief Accounting Officer Gil Alexis II sell 25,901 shares of common stock on September 24, 2025, for a total of $263,672. According to InvestingPro analysis, the stock has shown strong momentum with a 19.23% gain in the past week.

The shares were sold at prices ranging from $10.18 to $10.20, with the stock currently trading at a P/E ratio of 30.05. Following the transaction, Gil Alexis II directly owns 145,140 shares of Integral Ad Science Holding Corp. InvestingPro analysis indicates the stock may be undervalued, with 12 additional exclusive insights available to subscribers.

The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on June 12, 2025. For comprehensive insider trading analysis and detailed Fair Value calculations, investors can access the full Pro Research Report available on InvestingPro.

In other recent news, Integral Ad Science (IAS) reported strong financial results for the second quarter of 2025, exceeding analyst expectations. The company achieved an earnings per share (EPS) of $0.10, outperforming the projected $0.04, and generated revenue of $149.2 million, slightly surpassing the anticipated $143.39 million. Additionally, Integral Ad Science announced it will be acquired by private equity firm Novacap in an all-cash deal valued at approximately $1.9 billion. Under the agreement, Novacap will purchase all outstanding shares of IAS for $10.30 per share, which is a 22% premium over the company’s recent closing price. Following this acquisition announcement, Raymond James downgraded IAS from Outperform to Market Perform. Similarly, Stifel downgraded IAS to Hold from Buy, citing valuation concerns while acknowledging the company’s position as a leader in digital ad verification. These developments mark significant changes for Integral Ad Science, attracting attention from investors and analysts alike.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.